Researchers led by Princeton have found a clue that could lead to a targeted treatment for Hepatitis E, a liver virus that causes 20 million infections a year.

The J.P. Morgan event is known as the event for biotech and the investor community and, although typically aimed at generalists, bio journalists are always on…

As his inauguration nears, Donald Trump has interviewed an eclectic mix of candidates for his pick as National Institutes of Health (NIH) chief.

Philips revealed Thursday that it is developing a new surgical system that uses augmented reality to guide surgeons performing open and minimally invasive…

Continuous glucose monitors, effective tools for diabetes management, are generally covered by private health plans, but not by Medicare. Now, a new Centers…

The belief that the FDA is to undergo a major shift in thinking was given further credence as another curveball was thrown into the mix.

Most companies developing CAR-T therapies are firmly focused on blood cancers, but Celyad is bucking the trend with a trial that will include a tougher…

Kitov Pharmaceuticals has bought a 56% stake in TyrNovo to take control of a cancer program.

Nivalis is laying off 80% of its staff including its CEO and CMO.